Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

7.42
Delayed Data
As of Aug 03
 -0.24 / -3.13%
Today’s Change
6.18
Today|||52-Week Range
9.68
+3.06%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close7.66
Today’s open7.57
Day’s range7.33 - 7.85
Volume20,208
Average volume (3 months)19,616
Market cap$145.7M
Dividend yield--
Data as of 3:58pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)+22.50%
Earnings growth (next 5 years)--
Revenue growth (last year)+276.37%
P/E ratioNM
Price/Sales8.84
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.10-1.69%
MDWDMediwound Ltd-0.30-4.28%
AMPEAmpio Pharmaceutical...-0.08-2.99%
CRMECardiome Pharma Corp+0.31+3.42%
Data as of 4:02pm ET, 08/03/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$15.0M
Annual profit (last year)-$11.1M
Net profit margin-74.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer &
Head-Media Relations
Brian M. Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts